Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration

Therapeutic Drug Monitoring

Volumn 32, Issue 5, 2010, Pages 628-637

  Scheidweiler, Karl B ^a   Kolbrich Spargo, Erin A ^a,b   Kelly, Tamsin L ^c   Cone, Edward J ^d   Barnes, Allan J ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Southwest Institute of Forensic Science Dallas   (United States)

^c UNIVERSITY OF CANBERRA   (Australia)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clinical study; cocaine; oral fluid; pharmacokinetics

Indexed keywords

BENZOYLECGONINE; CITRIC ACID; COCAINE; DRUG METABOLITE; ECGONINE METHYL ESTER;

ADULT; ARTICLE; COCAINE DEPENDENCE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; MOUTH CAVITY; NORMAL HUMAN; PRIORITY JOURNAL; SALIVA LEVEL;

ADULT; AREA UNDER CURVE; COCAINE; COCAINE-RELATED DISORDERS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GINGIVAL CREVICULAR FLUID; HALF-LIFE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; PLASMA; SALIVA; SPECIMEN HANDLING; SUBSTANCE ABUSE DETECTION;

EID: 77957266877     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181f2b729     Document Type: Article

References (26)

1. Drummer OH. Introduction and review of collection techniques and applications of drug testing of oral fluid. Ther Drug Monit. 2008;30:203-206.
2. Drummer OH. Drug testing in oral fluid. Clin and Biocheml Rev. 2006;27: 147-159.
3. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009;55:1910-1931.
4. Langel K, Engblom C, Pehrsson A, et al. Drug testing in oral fluidevaluation of sample collection devices. J Anal Toxicol. 2008;32:393-401.
5. Crouch DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int. 2005;150:165-173.
6. Samyn N, Verstraete A, van Haeren C, et al. Analysis of drugs of abuse in saliva. Forensic Sci Rev. 1999;11:1-19.
7. Cone EJ, Kumor K, Thompson LK, et al. Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. J Anal Toxicol. 1988;12:200-206.
8. Schepers RJF, Oyler JM, Joseph RE Jr, et al. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003;49:121-132.
9. Jatlow P. Cocaine: analysis, pharmacokinetics, and metabolic disposition. Yale J Biol Med. 1988;61:105-113.
10. Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol. 1993;72:3-12.
11. Egred M, Davis GK. Cocaine and the heart. Postgrad Med J. 2005;81: 568-571.
12. Substance Abuse and Mental Health Services Administration. Results From the 2007 National Survey on Drug Use and Health: National Findings. Office of Applied Studies. NSDUH Series H-34. DHHS Publication No. SMA 08-4343. Rockville, MD: Department of Health and Human Services (DHHS); 2008.
13. European Monitoring Centre for Drugs and Drug Addiction. Annual Report: The State of the Drugs Problem in Europe. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction; 2008: 1-104.
14. Department of Health and Human Services. Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Federal Register. 2004;69:19673-19732.
15. Pil K, Raes E, Neste TVD, et al. Toxicological analyses in the DRUID epidemiological studies: analytical methods, target analytes and analytical cutoffs. The International Association of Forensic Toxicology Annual Meeting; August 27-30, 2007; Seattle, WA.
16. Walsh JM, Verstraete AG, Huestis MA, et al. Guidelines for research on drugged driving. Addiction. 2008;103:1258-1268.
17. Drummer OH, Gerostamoulos D, Chu M, et al. Drugs in oral fluid in randomly selected drivers. Forensic Sci Int. 2007;170:105-110.
18. Huestis MA, Oyler JM, Cone EJ, et al. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 1999;733:247-264.
19. Kim I, Barnes AJ, Oyler JM, et al. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem. 2002;48:1486-1496.
20. Kacinko SL, Barnes AJ, Schwilke EW, et al. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clin Chem. 2005;51:2085-2094.
21. Kolbrich E, Barnes A, Gorelick DA, et al. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol. 2006;30:501-510.
22. Cone EJ, Oyler J, Darwin WD. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. J Anal Toxicol. 1997; 21:465-475.
23. Jufer RA, Wstadik A, Walsh SL, et al. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J Anal Toxicol. 2000;24:467-477.
24. Jufer R,Walsh SL, Cone EJ, et al. Effect of repeated cocaine administration on detection times in oral fluid and urine. J Anal Toxicol. 2006;30:458-462.
25. Jenkins AJ, Oyler JM, Cone EJ. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol. 1995;19:359-374.
26. Kato K, Hillsgrove M, Weinhold L, et al. Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. J Anal Toxicol. 1993;17:338-341.